Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Roquefort Investments PLC ( (GB:ROQ) ) just unveiled an announcement.
Roquefort Therapeutics PLC has announced the posting of its Notice of Annual General Meeting to shareholders, with the meeting scheduled for June 26, 2025, in London. This announcement is a routine part of corporate governance, allowing shareholders to engage with the company’s leadership and discuss strategic directions, potentially impacting the company’s future operations and stakeholder interests.
More about Roquefort Investments PLC
Roquefort Therapeutics PLC is a biotech company listed on the Main Market, specializing in developing first-in-class medicines targeting the high-value and high-growth immunology and oncology markets. The company’s portfolio includes five novel, patent-protected pre-clinical anti-cancer and immunology assets.
Average Trading Volume: 2,756,190
Technical Sentiment Signal: Sell
Current Market Cap: £2.79M
See more insights into ROQ stock on TipRanks’ Stock Analysis page.